Artificial Intelligence to Scale Early Rheumatic Heart Disease Detection
SHIELD 1
1 other identifier
interventional
62
1 country
1
Brief Summary
The main goal of this project is to see if RADAR (a machine-learning AI model) can help make rheumatic heart disease (RHD) screening easier to expand. Specifically, the project will test whether RADAR can screen as accurately-or more accurately-than current methods, and whether it can be used effectively in different low-resource settings. The aim is to show that RADAR could be adopted and used widely around the world.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 14, 2026
CompletedFirst Posted
Study publicly available on registry
May 20, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2028
Study Completion
Last participant's last visit for all outcomes
June 1, 2028
May 20, 2026
May 1, 2026
2 years
May 14, 2026
May 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of Provider RHD Screening
The number of correctly identified (positive or negative) screenings divided by the total number of exams.
1 year
Secondary Outcomes (1)
Interpretation Sensitivity
6 months
Study Arms (2)
Standard non-AI echocardiography
NO INTERVENTIONIn the Standard non-AI Echocardiography arm, participants will receive the current standard of care under the ADUNU program, which includes a single parasternal long-axis view with black-and-white and color Doppler imaging. Providers have been trained to recognize mitral regurgitation greater than 1.5 or 2 cm (based on person's age38), any aortic insufficiency, qualitatively reduced left ventricular systolic function, and pericardial effusion. Detection of any of these findings constitutes a screen positive, prompting referral for a confirmatory echocardiogram.
RADAR-AI-assisted echocardiography
EXPERIMENTALIn the RADAR-AI-Assisted Echocardiography arm, participants will undergo AI-assisted screening according to the well-established RADAR protocol including the same image acquisition protocol but interpreted by the tablet-based software based on two independent AI algorithms 1) RHD positive or negative and 2) mitral regurgitation jet length. Positive findings from either algorithm constitutes a screen positive. Providers may also refer for other concerns.
Interventions
Continue standard of care with AI-assisted echocardiography
Eligibility Criteria
You may qualify if:
- Employed at a participating ADUNU facility
- Holds a designated role in the ADUNU program as a nurse screener
You may not qualify if:
- None. The pragmatic trial design includes all eligible staff at participating facilities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Children's Hospital Medical Center, Cincinnatilead
- Uganda Heart Institutecollaborator
- Children's National Health System, Washington DCcollaborator
- Ochsner Health Systemcollaborator
Study Sites (1)
Uganda Heart Institute
Kampala, Uganda
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea Beaton
Children's Hospital Medical Center, Cincinnati
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Masking Details
- Cardiologists who make up the adjudication panel.
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 14, 2026
First Posted
May 20, 2026
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
June 1, 2028
Study Completion (Estimated)
June 1, 2028
Last Updated
May 20, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share